ABHD12

Chr 20AR

abhydrolase domain containing 12, lysophospholipase

Also known as: ABHD12A, BEM46L2, C20orf22, PHARC, dJ965G21.2, hABHD12

This gene encodes an enzyme that catalyzes the hydrolysis of 2-arachidonoyl glycerol (2-AG), the main endocannabinoid lipid transmitter that acts on cannabinoid receptors, CB1 and CB2. The endocannabinoid system is involved in a wide range of physiological processes, including neurotransmission, mood, appetite, pain appreciation, addiction behavior, and inflammation. Mutations in this gene are associated with the neurodegenerative disease, PHARC (polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataract), resulting from an inborn error of endocannabinoid metabolism. Alternatively spliced transcript variants encoding different isoforms have been noted for this gene.[provided by RefSeq, Jan 2011]

GeneReviewsOMIMResearchGenerating clinical summary…
LOFmechanismARLOEUF 0.761 OMIM phenotype
Clinical SummaryABHD12
🧬
Gene-Disease Validity (ClinGen)
PHARC syndrome · ARDefinitive

Definitive — sufficient evidence for diagnostic panels

Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
58 unique Pathogenic / Likely Pathogenic· 269 VUS of 640 total submissions
📖
GeneReview available — ABHD12
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint?
0.76LOEUF
pLI 0.000
Z-score 2.47
OE 0.47 (0.300.76)
Tolerant

Typical tolerance to LoF variation

Missense Constraint?
0.19Z-score
OE missense 0.96 (0.861.08)
210 obs / 218.1 exp
Tolerant

Mild missense constraint

Observed / Expected Ratios?
LoF OE?0.47 (0.300.76)
00.351.4
Missense OE?0.96 (0.861.08)
00.61.4
Synonymous OE?1.01
01.21.6
LoF obs/exp: 12 / 25.5Missense obs/exp: 210 / 218.1Syn Z: -0.07
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
definitiveABHD12-related polyneuropathy, hearing loss, ataxia, retinitis pigmentosa, and cataractLOFAR

This gene — mechanism propensity

Predictions shown for reference only — model trained on dominant genes, not applicable to AR conditions.

DN
0.6937th %ile
GOF
0.5856th %ile
LOF
0.2777th %ile

The Badonyi & Marsh prediction model was trained exclusively on dominant disease genes. Predictions are not reliable for genes with autosomal recessive inheritance and are shown at reduced opacity for reference only.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

640 submitted variants in ClinVar

Classification Summary

Pathogenic37
Likely Pathogenic21
VUS269
Likely Benign221
Benign51
Conflicting30
37
Pathogenic
21
Likely Pathogenic
269
VUS
221
Likely Benign
51
Benign
30
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
29
2
6
0
37
Likely Pathogenic
17
3
1
0
21
VUS
6
226
32
5
269
Likely Benign
0
3
132
86
221
Benign
0
3
43
5
51
Conflicting
30
Total5223721496629

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

22 pathogenic / likely-pathogenic (of 36) ClinVar copy-number / structural variants overlap ABHD12 — these span large chromosomal regions, not the gene specifically, and are excluded from the counts above. Explore in CNV tools →

Protein Context — Lollipop Plot

ABHD12 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →